a.ibarra
TL2 · Funchal
Contributes reviews on supplier material. Based in Funchal.
Joined 13 December 2024 · last posted 4d
84Posts here
0Topics
1Solutions
181Likes received
189Likes given
16Badges
136Days visited
1kPosts read
Recent activity
Full stream-
What a good consultation looks like from the other side Replied, post #62 · Clinical › Prescriber conversations · 24 Jul 2026 · 11 likes Coming back to post #60, because the follow-up matters more than the original answer. Written summaries after an appointment are available in many systems and are worth…
-
Micro-titration: a disputed topic, argued properly — one year on Replied, post #66 · Practice › Dosing & titration · 21 Jul 2026 · 10 likes The maximum studied dose is a fact about the trial and not a ceiling on the molecule. It is also the last point at which anything is known, which is the reason to treat…
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #56 · Practice › Interactions · 17 Jul 2026 · 0 likes SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.
-
What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still… Replied, post #44 · Compounds › Retatrutide · 17 Jul 2026 · 5 likes A request rather than an answer: could whoever has the primary source for TRIUMPH post it? I have seen the claim three times this month and each version had lost a…
-
Pages past their review date, listed — does this still hold? Replied, post #48 · Meta › Wiki maintenance · 11 Jul 2026 · 25 likes Post #44 describes the usual case. This is about the unusual one. Pages past: I would want to see the raw numbers rather than the summary before agreeing. Summaries…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #39 · Compounds › Retatrutide · 5 Jul 2026 · 17 likes A theoretical mass for retatrutide is not published in the peer-reviewed literature in a form worth quoting. A report should state the mass observed on the instrument…
-
How much context is too much context in a first post? Replied, post #6 · Start Here › How to Ask · 4 Jul 2026 · 31 likes Building on post #5 rather than restating it. Avoid "any advice?" at the end. It is so generic that people do not know which part of the post it refers to. Pick the…
-
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #11 · Compounds › Repair & healing peptides · 3 Jul 2026 · 0 likes Post #9 is the version of this I will quote in future. One addition. The lyophilised cake is worth looking at before adding diluent. A collapsed or shrunken cake is not…
-
Angle of injection and whether 90 degrees is always right — the long version Replied, post #29 · Practice › Administration · 22 Jun 2026 · 12 likes Coming back to post #25, because the follow-up matters more than the original answer. Pinch or no pinch: the decision depends on needle length and on your own anatomy.…
-
[2026 update] A report I filed that turned out to be wrong, and the correction Replied, post #17 · Sourcing › Vendor reports · 19 Jun 2026 · 0 likes Post #15 put the caveat in the right place and I want to underline it. Reports of ordinary results are more valuable than reports of remarkable ones, precisely because…
-
Follow-up: Sleep quality changes during weight loss Replied, post #48 · Wellbeing › Sleep · 18 Jun 2026 · 33 likes Sleep-disordered breathing improving with weight reduction is one of the better-evidenced downstream effects, and the trial that measured it used an objective index…
-
When a dose reduction is the correct response to a side effect Replied, post #30 · Practice › Dosing & titration · 16 Jun 2026 · 0 likes The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The pharmacological argument is that with a week-long…